BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1766 related articles for article (PubMed ID: 17878513)

  • 1. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.
    Kobori H; Nangaku M; Navar LG; Nishiyama A
    Pharmacol Rev; 2007 Sep; 59(3):251-87. PubMed ID: 17878513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanisms responsible for the renoprotective effects of renin-angiotensin inhibitors].
    Nishiyama A
    Yakugaku Zasshi; 2012; 132(4):455-9. PubMed ID: 22465922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent regulation of renin-angiotensin-aldosterone system in the kidney.
    Nishiyama A; Kobori H
    Clin Exp Nephrol; 2018 Dec; 22(6):1231-1239. PubMed ID: 29600408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of stimulated intrarenal angiotensinogen in hypertension.
    Satou R; Shao W; Navar LG
    Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):181-90. PubMed ID: 25987608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Updates on the Proximal Tubule Renin-Angiotensin System in Angiotensin II-Dependent Hypertension.
    Li XC; Zhuo JL
    Curr Hypertens Rep; 2016 Aug; 18(8):63. PubMed ID: 27372447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal responses to AT1 receptor blockade.
    Navar LG; Harrison-Bernard LM; Imig JD; Cervenka L; Mitchell KD
    Am J Hypertens; 2000 Jan; 13(1 Pt 2):45S-54S. PubMed ID: 10678288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrarenal production of angiotensin II.
    Navar LG; Imig JD; Zou L; Wang CT
    Semin Nephrol; 1997 Sep; 17(5):412-22. PubMed ID: 9316209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrarenal angiotensin II generation and renal effects of AT1 receptor blockade.
    Navar LG; Harrison-Bernard LM; Imig JD; Wang CT; Cervenka L; Mitchell KD
    J Am Soc Nephrol; 1999 Apr; 10 Suppl 12():S266-72. PubMed ID: 10201881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of collecting duct renin and (pro)renin receptor in hypertension: mini review.
    Gonzalez AA; Prieto MC
    Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):191-200. PubMed ID: 25780059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intrarenal renin-angiotensin system in hypertension.
    Carey RM
    Adv Chronic Kidney Dis; 2015 May; 22(3):204-10. PubMed ID: 25908469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intrarenal renin-angiotensin system.
    Burns KD; Homma T; Harris RC
    Semin Nephrol; 1993 Jan; 13(1):13-30. PubMed ID: 8434183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the intrarenal renin-angiotensin system in the progression of renal disease.
    Urushihara M; Kagami S
    Pediatr Nephrol; 2017 Sep; 32(9):1471-1479. PubMed ID: 27380400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension.
    Navar LG; Prieto MC; Satou R; Kobori H
    Curr Opin Pharmacol; 2011 Apr; 11(2):180-6. PubMed ID: 21339086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
    Li XC; Zhang J; Zhuo JL
    Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease.
    Loghman-Adham M; Soto CE; Inagami T; Cassis L
    Am J Physiol Renal Physiol; 2004 Oct; 287(4):F775-88. PubMed ID: 15187005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrarenal renin-angiotensin system activity is augmented after initiation of dialysis.
    Ohashi N; Isobe S; Ishigaki S; Suzuki T; Ono M; Fujikura T; Tsuji T; Kato A; Ozono S; Yasuda H
    Hypertens Res; 2017 Apr; 40(4):364-370. PubMed ID: 27761002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II.
    Zhuo JL; Li XC
    Peptides; 2011 Jul; 32(7):1551-65. PubMed ID: 21699940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications.
    Wolf G; Ritz E
    Kidney Int; 2005 Mar; 67(3):799-812. PubMed ID: 15698420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II and its receptors in the diabetic kidney.
    Burns KD
    Am J Kidney Dis; 2000 Sep; 36(3):449-67. PubMed ID: 10977776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiology and Pathophysiology of the Intrarenal Renin-Angiotensin System: An Update.
    Yang T; Xu C
    J Am Soc Nephrol; 2017 Apr; 28(4):1040-1049. PubMed ID: 28255001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 89.